Frontage launches $205m Hong Kong spin-off
Chinese drug services provider Frontage Holdings Corp has kicked off bookbuilding for its IPO, vying for proceeds of up to HK$1.60bn ($204.6m).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: